Planet Labs PBC (PL) Financials

$3.98 +0.01 (+0.13%)

As of 11:20 AM Eastern

Annual Income Statements for Planet Labs PBC

This table shows Planet Labs PBC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021	2020
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020
Net Income / (Loss) Attributable to Common Shareholders	-123	-141	-162	-137	-127	-124
Consolidated Net Income / (Loss)	-123	-141	-162	-137	-127	-124
Net Income / (Loss) Continuing Operations	-123	-141	-162	-137	-127	-124
Total Pre-Tax Income	-121	-140	-161	-135	-126	-124
Total Operating Income	-116	-170	-176	-128	-87	-106
Total Gross Profit	140	113	94	48	26	-6.66
Total Revenue	244	221	191	131	113	96
Operating Revenue	244	221	191	131	113	96
Total Cost of Revenue	105	108	97	83	87	102
Operating Cost of Revenue	105	108	97	83	87	102
Total Operating Expenses	256	283	270	176	113	100
Selling, General & Admin Expense	77	80	81	57	32	27
Marketing Expense	78	86	78	53	37	35
Research & Development Expense	101	116	111	67	44	38
Total Other Income / (Expense), net	-4.61	30	15	-6.96	-39	-17
Interest & Investment Income	10	15	7.67	0.02	0.05	-
Other Income / (Expense), net	-15	15	6.88	3.48	-30	1.35
Income Tax Expense	2.46	0.82	0.85	2.11	1.07	0.13
Basic Earnings per Share	($0.42)	($0.50)	($0.61)	($1.72)	($2.87)	($2.89)
Weighted Average Basic Shares Outstanding	292.12M	279.59M	267.13M	79.61M	44.21M	42.86M
Diluted Earnings per Share	($0.42)	($0.50)	($0.61)	($1.72)	($2.87)	($2.89)
Weighted Average Diluted Shares Outstanding	292.12M	279.59M	267.13M	79.61M	44.21M	42.86M
Weighted Average Basic & Diluted Shares Outstanding	302.25M	290.62M	274.97M	267.90M	-	-

This table shows Planet Labs PBC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-35	-20	-39	-29	-30	-38	-38	-34	-38	-40	-40
Consolidated Net Income / (Loss)	-35	-20	-39	-29	-30	-38	-38	-34	-38	-40	-40
Net Income / (Loss) Continuing Operations	-35	-20	-39	-29	-30	-38	-38	-34	-38	-40	-40
Total Pre-Tax Income	-34	-20	-38	-29	-31	-38	-37	-34	-38	-40	-39
Total Operating Income	-19	-23	-40	-35	-34	-48	-43	-45	-43	-43	-43
Total Gross Profit	38	38	32	32	32	26	26	28	29	25	23
Total Revenue	62	61	61	60	59	55	54	53	53	50	48
Operating Revenue	62	61	61	60	59	55	54	53	53	50	48
Total Cost of Revenue	23	24	29	29	26	29	27	25	24	25	25
Operating Cost of Revenue	23	24	29	29	26	29	27	25	24	25	25
Total Operating Expenses	58	60	72	66	66	74	70	73	72	68	66
Selling, General & Admin Expense	19	18	21	19	18	20	21	22	20	21	20
Marketing Expense	16	17	24	21	20	21	22	23	20	19	19
Research & Development Expense	23	25	27	26	28	33	27	28	32	28	27
Total Other Income / (Expense), net	-15	2.55	1.81	5.72	3.40	10	5.89	11	4.79	2.84	3.27
Interest & Investment Income	1.97	2.41	2.77	3.11	3.66	3.45	3.80	4.51	3.40	2.85	1.31
Other Income / (Expense), net	-17	0.14	-0.97	2.61	-0.26	6.76	2.09	6.05	1.39	-0.02	1.95
Income Tax Expense	1.12	0.00	0.90	0.44	-0.43	0.36	0.58	0.31	-0.06	0.44	0.15
Basic Earnings per Share	($0.12)	($0.07)	($0.13)	($0.10)	($0.10)	($0.13)	($0.14)	($0.13)	($0.14)	($0.15)	($0.15)
Weighted Average Basic Shares Outstanding	292.12M	293.34M	290.36M	288.27M	279.59M	284.20M	275.05M	272.35M	267.13M	267.95M	266.21M
Diluted Earnings per Share	($0.12)	($0.07)	($0.13)	($0.10)	($0.10)	($0.13)	($0.14)	($0.13)	($0.14)	($0.15)	($0.15)
Weighted Average Diluted Shares Outstanding	292.12M	293.34M	290.36M	288.27M	279.59M	284.20M	275.05M	272.35M	267.13M	267.95M	266.21M
Weighted Average Basic & Diluted Shares Outstanding	302.25M	296.71M	293.48M	290.77M	290.62M	287.63M	285.66M	276.03M	274.97M	272.10M	269.88M

This table details how cash moves in and out of Planet Labs PBC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021	2020
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020
Net Change in Cash & Equivalents	28	-86	-309	420	49	-52
Net Cash From Operating Activities	-14	-51	-74	-42	-4.03	-34
Net Cash From Continuing Operating Activities	-14	-51	-74	-42	-4.03	-34
Net Income / (Loss) Continuing Operations	-123	-141	-162	-137	-127	-124
Consolidated Net Income / (Loss)	-123	-141	-162	-137	-127	-124
Depreciation Expense	46	48	43	45	62	78
Non-Cash Adjustments To Reconcile Net Income	64	43	69	39	43	17
Changes in Operating Assets and Liabilities, net	-0.42	-1.26	-24	8.19	15	-6.04
Net Cash From Investing Activities	58	-34	-242	-25	-31	-27
Net Cash From Continuing Investing Activities	58	-34	-242	-25	-31	-27
Purchase of Property, Plant & Equipment	-50	-42	-13	-15	-30	-24
Acquisitions	-5.85	-7.54	-3.82	-9.62	0.00	-2.46
Purchase of Investments	-140	-189	-280	0.00	0.00	-
Sale and/or Maturity of Investments	254	207	55	0.00	0.00	-
Other Investing Activities, net	-0.30	-1.39	-0.56	-0.60	-0.67	-0.61
Net Cash From Financing Activities	-16	-1.60	7.86	489	84	8.73
Net Cash From Continuing Financing Activities	-16	-1.60	7.86	489	84	8.73
Repayment of Debt	-0.74	-0.02	-0.50	-67	-2.59	-51
Issuance of Common Equity	1.55	0.00	0.00	-	-	-
Other Financing Activities, net	-16	-1.58	8.36	556	0.54	0.26
Effect of Exchange Rate Changes	-0.20	0.02	-0.40	-1.55	-0.31	-
Cash Income Taxes Paid	1.80	-0.16	3.10	0.88	1.08	0.00

This table details how cash moves in and out of Planet Labs PBC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Change in Cash & Equivalents	-20	-17	41	24	-18	-4.77	-22	-42	-17	-63	-223
Net Cash From Operating Activities	-6.30	4.08	-7.86	-4.30	-6.84	-23	9.60	-31	-15	-30	-22
Net Cash From Continuing Operating Activities	-6.30	4.08	-7.86	-4.30	-6.84	-23	9.60	-31	-15	-30	-22
Net Income / (Loss) Continuing Operations	-35	-20	-39	-29	-30	-38	-38	-34	-38	-40	-40
Consolidated Net Income / (Loss)	-35	-20	-39	-29	-30	-38	-38	-34	-38	-40	-40
Depreciation Expense	9.27	10	13	13	12	14	12	10	9.33	11	12
Non-Cash Adjustments To Reconcile Net Income	28	12	12	12	13	5.77	15	9.41	15	19	18
Changes in Operating Assets and Liabilities, net	-8.67	2.41	5.50	0.35	-1.17	-4.26	20	-16	-0.83	-20	-13
Net Cash From Investing Activities	-13	-11	51	30	-9.55	20	-32	-13	-4.79	-34	-200
Net Cash From Continuing Investing Activities	-13	-11	51	30	-9.55	20	-32	-13	-4.79	-34	-200
Purchase of Property, Plant & Equipment	-13	-8.86	-17	-11	-10	-8.65	-17	-7.08	-2.02	-2.97	-4.27
Acquisitions	-0.23	-0.27	-0.27	-5.09	-	-7.54	-	0.00	-3.82	-	-
Purchase of Investments	-35	-24	-54	-28	-23	-38	-92	-35	-41	-44	-195
Sale and/or Maturity of Investments	35	22	122	75	24	75	78	30	42	13	-
Net Cash From Financing Activities	-0.23	-10	-2.73	-2.38	-1.24	-1.95	0.19	1.40	1.48	2.33	-0.50
Net Cash From Continuing Financing Activities	-0.23	-10	-2.73	-2.38	-1.24	-1.95	0.19	1.40	1.48	2.33	-0.50
Repayment of Debt	-0.13	-0.27	0.04	-0.38	-	-	-0.02	0.00	-0.63	-	-
Issuance of Common Equity	0.47	0.38	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	-0.57	-10	-3.47	-2.00	-1.24	-1.95	0.21	1.40	1.78	2.33	-0.30
Effect of Exchange Rate Changes	-0.28	0.11	0.24	-0.28	0.08	-0.22	-0.02	0.18	1.38	-0.66	-0.47

This table presents Planet Labs PBC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021	2020
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	12/31/2020
Total Assets	634	702	753	821	399	0.09
Total Current Assets	302	370	476	552	125	0.00
Cash & Equivalents	118	84	182	491	71	0.00
Restricted Cash	6.60	8.36	0.53	-	-	-
Short-Term Investments	104	215	227	0.00	-	-
Accounts Receivable	56	43	39	44	47	-
Prepaid Expenses	18	20	27	16	7.13	0.00
Plant, Property, & Equipment, net	122	113	108	133	160	0.00
Total Noncurrent Assets	210	218	169	137	114	0.09
Goodwill	136	136	113	103	88	-
Intangible Assets	46	47	26	25	18	-
Other Noncurrent Operating Assets	22	25	30	8.46	7.97	0.09
Other Noncurrent Nonoperating Assets	5.35	9.97	-	-	-	-
Total Liabilities & Shareholders' Equity	634	702	753	821	399	0.09
Total Liabilities	193	184	177	173	292	0.06
Total Current Liabilities	142	137	122	132	109	0.06
Accounts Payable	2.60	2.60	6.90	2.85	1.45	0.01
Accrued Expenses	43	45	46	49	30	0.05
Current Deferred Revenue	82	72	52	64	58	-
Other Current Liabilities	15	17	17	16	11	-
Total Noncurrent Liabilities	50	47	54	41	183	0.00
Noncurrent Deferred Revenue	11	5.29	2.88	4.38	18	-
Other Noncurrent Operating Liabilities	39	42	51	37	9.26	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	441	518	576	648	108	0.02
Total Preferred & Common Equity	441	518	576	648	108	0.02
Total Common Equity	441	518	576	648	107	0.02
Common Stock	1,645	1,596	1,513	1,423	746	0.03
Retained Earnings	-1,203	-1,080	-939	-777	-640	-0.00
Accumulated Other Comprehensive Income / (Loss)	-1.10	1.59	2.27	2.10	1.77	-

This table presents Planet Labs PBC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Period end date	10/31/2024	7/31/2024	4/30/2024	10/31/2023	7/31/2023	4/30/2023	10/31/2022	7/31/2022	4/30/2022
Total Assets	631	658	675	714	720	723	747	768	796
Total Current Assets	302	327	346	388	428	435	481	504	527
Cash & Equivalents	139	148	107	102	119	141	199	262	484
Restricted Cash	6.53	8.80	8.80	7.88	-	-	-	-	-
Short-Term Investments	103	101	168	213	249	235	226	196	-
Accounts Receivable	39	44	39	45	40	39	29	26	25
Prepaid Expenses	14	25	23	20	20	19	26	20	18
Plant, Property, & Equipment, net	117	113	111	114	120	118	115	121	125
Total Noncurrent Assets	212	218	217	212	172	171	151	143	143
Goodwill	137	137	137	136	113	113	103	103	103
Intangible Assets	47	48	47	41	28	26	24	24	25
Other Noncurrent Operating Assets	23	24	23	24	26	26	24	15	15
Other Noncurrent Nonoperating Assets	4.44	9.54	9.56	10	5.71	5.66	-	-	-
Total Liabilities & Shareholders' Equity	631	658	675	714	720	723	747	768	796
Total Liabilities	166	185	174	180	181	164	153	154	165
Total Current Liabilities	129	140	126	131	116	112	110	122	129
Accounts Payable	3.57	2.39	3.13	4.59	3.83	15	2.56	2.19	3.17
Accrued Expenses	44	57	43	42	38	34	43	48	43
Current Deferred Revenue	66	65	64	67	57	45	48	52	61
Other Current Liabilities	15	16	16	17	18	18	17	20	22
Total Noncurrent Liabilities	37	45	48	49	65	52	43	32	36
Noncurrent Deferred Revenue	11	12	13	7.76	18	2.47	0.00	0.00	0.00
Other Noncurrent Operating Liabilities	26	33	35	41	46	50	43	32	36
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	465	473	500	534	540	559	594	614	631
Total Preferred & Common Equity	465	473	500	534	540	559	594	614	631
Total Common Equity	465	473	500	534	540	559	594	614	631
Common Stock	1,631	1,620	1,609	1,584	1,550	1,531	1,495	1,472	1,450
Retained Earnings	-1,168	-1,148	-1,109	-1,050	-1,012	-974	-901	-861	-822
Accumulated Other Comprehensive Income / (Loss)	1.35	1.25	0.55	-0.24	1.34	1.68	0.94	2.72	2.27

This table displays calculated financial ratios and metrics derived from Planet Labs PBC's official financial filings.

Metric	2025	2024	2023	2022	2021	2020
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020
Growth Metrics	-	-	-	-	-	-
Revenue Growth	10.72%	15.39%	45.76%	15.94%	18.21%	0.00%
EBITDA Growth	20.58%	14.34%	-63.16%	-46.89%	-100.66%	0.00%
EBIT Growth	15.55%	8.11%	-35.50%	-6.19%	-11.61%	0.00%
NOPAT Growth	31.59%	3.37%	-37.19%	-46.44%	17.86%	0.00%
Net Income Growth	12.32%	13.25%	-18.12%	-7.88%	-2.74%	0.00%
EPS Growth	16.00%	18.03%	64.53%	40.07%	0.69%	0.00%
Operating Cash Flow Growth	71.66%	31.41%	-75.15%	-948.20%	88.05%	0.00%
Free Cash Flow Firm Growth	42.55%	-15.48%	-181.89%	82.04%	0.00%	0.00%
Invested Capital Growth	3.23%	20.36%	5.93%	-21.33%	848,137.29%	0.00%
Revenue Q/Q Growth	1.12%	2.74%	9.02%	-36.68%	0.00%	0.00%
EBITDA Q/Q Growth	-5.15%	8.04%	-0.94%	56.89%	0.00%	0.00%
EBIT Q/Q Growth	-1.43%	4.39%	0.40%	30.17%	0.00%	0.00%
NOPAT Q/Q Growth	11.14%	4.91%	7.63%	15.11%	0.00%	0.00%
Net Income Q/Q Growth	-4.29%	5.23%	4.78%	30.34%	0.00%	0.00%
EPS Q/Q Growth	-5.00%	7.41%	-190.48%	61.44%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	3.63%	13.59%	7.94%	-95.60%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	14.28%	2.43%	56.19%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-1.96%	0.14%	-1.22%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	57.18%	51.18%	49.15%	36.75%	22.78%	-6.95%
EBITDA Margin	-34.93%	-48.70%	-65.60%	-58.61%	-46.26%	-27.25%
Operating Margin	-47.52%	-76.91%	-91.85%	-97.59%	-77.27%	-111.20%
EBIT Margin	-53.61%	-70.28%	-88.25%	-94.94%	-103.66%	-109.79%
Profit (Net Income) Margin	-50.42%	-63.67%	-84.69%	-104.51%	-112.31%	-129.22%
Tax Burden Percent	102.04%	100.58%	100.53%	101.56%	100.85%	100.11%
Interest Burden Percent	92.17%	90.06%	95.45%	108.38%	107.43%	117.58%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-39.84%	-64.65%	-75.84%	-50.12%	-61.15%	-315,771.19%
ROIC Less NNEP Spread (ROIC-NNEP)	-24.64%	-58.68%	-67.17%	-26.26%	-203.35%	0.00%
Return on Net Nonoperating Assets (RNNOA)	14.16%	38.96%	49.38%	13.83%	-175.25%	0.00%
Return on Equity (ROE)	-25.68%	-25.68%	-26.46%	-36.29%	-236.39%	0.00%
Cash Return on Invested Capital (CROIC)	-43.02%	-83.13%	-81.60%	-26.24%	-261.10%	0.00%
Operating Return on Assets (OROA)	-19.61%	-21.32%	-21.45%	-20.41%	-58.74%	-122,576.09%
Return on Assets (ROA)	-18.45%	-19.32%	-20.58%	-22.47%	-63.65%	-144,272.89%
Return on Common Equity (ROCE)	-25.68%	-25.68%	-26.46%	-36.29%	-236.37%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-27.92%	-27.12%	-28.11%	-21.15%	-118.22%	0.00%
Net Operating Profit after Tax (NOPAT)	-81	-119	-123	-90	-61	-75
NOPAT Margin	-33.27%	-53.84%	-64.30%	-68.32%	-54.09%	-77.84%
Net Nonoperating Expense Percent (NNEP)	-15.21%	-5.97%	-8.66%	-23.86%	142.21%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-18.42%	-22.94%	-21.35%	-	-	-
Cost of Revenue to Revenue	42.82%	48.82%	50.85%	63.25%	77.22%	106.95%
SG&A Expenses to Revenue	31.57%	36.27%	42.22%	43.19%	28.40%	28.22%
R&D to Revenue	41.34%	52.71%	57.99%	50.82%	38.73%	39.56%
Operating Expenses to Revenue	104.70%	128.09%	141.01%	134.35%	100.05%	104.25%
Earnings before Interest and Taxes (EBIT)	-131	-155	-169	-125	-117	-105
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-85	-107	-125	-77	-52	-26
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	4.10	1.25	2.34	0.41	2.79	12,711.86
Price to Tangible Book Value (P/TBV)	7.00	1.94	3.08	0.51	208.62	12,711.86
Price to Revenue (P/Rev)	7.41	2.95	7.04	2.00	2.65	3.13
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	7.63	1.71	5.62	0.00	1.96	12,711.86
Enterprise Value to Revenue (EV/Rev)	6.47	1.55	4.90	0.00	3.47	3.13
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	1.52	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	1.45	0.00
Financial Leverage	-0.57	-0.66	-0.74	-0.53	0.86	0.00
Leverage Ratio	1.39	1.33	1.29	1.62	3.71	3.63
Compound Leverage Factor	1.28	1.20	1.23	1.75	3.99	4.27
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	60.38%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	3.04%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	57.34%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	39.61%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	-3.13	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	-1.77	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	-2.97	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	-2.68	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	-1.51	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	-2.54	0.00
Altman Z-Score	2.99	-0.05	2.91	-0.14	-2.26	-33.23
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	2.13	2.71	3.89	4.18	1.15	0.00
Quick Ratio	1.96	2.50	3.66	4.05	1.09	0.00
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-88	-153	-132	-47	-261	0.00
Operating Cash Flow to CapEx	-28.97%	-119.57%	-579.41%	-282.71%	-13.37%	-139.77%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-4.49	-29.79	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-4.03	-0.46	-1.82
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-5.46	-3.89	-3.13
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.37	0.30	0.24	0.22	0.57	1,116.45
Accounts Receivable Turnover	4.93	5.37	4.59	2.87	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	2.08	1.99	1.58	0.90	0.00	0.00
Accounts Payable Turnover	40.20	22.68	19.95	38.63	119.97	9,524.93
Days Sales Outstanding (DSO)	74.05	68.03	79.51	127.24	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	9.08	16.09	18.30	9.45	3.04	0.04
Cash Conversion Cycle (CCC)	64.98	51.94	61.21	117.80	-3.04	-0.04
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	207	201	167	157	200	0.02
Invested Capital Turnover	1.20	1.20	1.18	0.73	1.13	4,056.61
Increase / (Decrease) in Invested Capital	6.49	34	9.33	-43	200	0.00
Enterprise Value (EV)	1,581	343	938	-228	393	300
Market Capitalization	1,810	650	1,347	263	300	300
Book Value per Share	$1.49	$1.80	$2.12	$15.03	$2.43	$0.00
Tangible Book Value per Share	$0.87	$1.16	$1.61	$12.06	$0.03	$0.00
Total Capital	441	518	576	648	271	0.02
Total Debt	0.00	0.00	0.00	0.00	164	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	156	0.00
Net Debt	-229	-307	-409	-491	93	0.00
Capital Expenditures (CapEx)	50	42	13	15	30	24
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-69	-74	-56	-71	-46	-0.06
Debt-free Net Working Capital (DFNWC)	160	234	353	419	25	-0.06
Net Working Capital (NWC)	160	234	353	419	17	-0.06
Net Nonoperating Expense (NNE)	42	22	39	47	66	49
Net Nonoperating Obligations (NNO)	-234	-317	-409	-491	93	0.00
Total Depreciation and Amortization (D&A)	46	48	43	48	65	79
Debt-free, Cash-free Net Working Capital to Revenue	-28.04%	-33.42%	-29.22%	-54.33%	-40.94%	-0.06%
Debt-free Net Working Capital to Revenue	65.54%	105.80%	184.78%	319.70%	21.96%	-0.06%
Net Working Capital to Revenue	65.54%	105.80%	184.78%	319.70%	14.68%	-0.06%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.42)	($0.50)	($0.61)	($1.72)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	292.12M	279.59M	267.13M	79.61M	0.00	0.00
Adjusted Diluted Earnings per Share	($0.42)	($0.50)	($0.61)	($1.72)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	292.12M	279.59M	267.13M	79.61M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	302.25M	290.62M	274.97M	267.90M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-81	-119	-123	-90	-61	-75
Normalized NOPAT Margin	-33.27%	-53.84%	-64.30%	-68.32%	-54.09%	-77.84%
Pre Tax Income Margin	-49.41%	-63.30%	-84.24%	-102.90%	-111.37%	-129.09%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-11.91	-13.37	-5.69
NOPAT to Interest Expense	0.00	0.00	0.00	-8.57	-6.98	-4.03
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-13.33	-16.80	-6.99
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-9.99	-10.41	-5.34
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Planet Labs PBC's official financial filings.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.59%	10.63%	13.64%	14.68%	11.09%	11.42%	10.96%	31.34%	42.61%	56.80%	59.34%
EBITDA Growth	-18.52%	55.03%	5.64%	33.60%	29.39%	13.80%	0.22%	12.72%	-4.82%	-20.66%	-405.52%
EBIT Growth	-5.40%	45.32%	1.59%	17.30%	17.24%	3.65%	-1.25%	12.49%	1.62%	-10.66%	-131.41%
NOPAT Growth	42.90%	52.76%	8.56%	22.65%	20.55%	-12.26%	-1.50%	6.33%	25.38%	-50.58%	-75.71%
Net Income Growth	-16.85%	47.16%	-1.82%	14.95%	20.49%	5.55%	3.93%	22.35%	17.67%	3.14%	-94.12%
EPS Growth	-20.00%	46.15%	7.14%	23.08%	28.57%	13.33%	6.67%	23.53%	-153.85%	82.95%	67.39%
Operating Cash Flow Growth	7.93%	117.82%	-181.88%	85.96%	53.85%	24.56%	143.09%	-368.33%	30.10%	-138.45%	-82.77%
Free Cash Flow Firm Growth	65.27%	58.94%	-66.13%	15.21%	-47.14%	67.23%	78.25%	65.16%	-1,576.07%	-172.91%	-165.92%
Invested Capital Growth	3.23%	5.44%	23.75%	16.26%	20.36%	18.73%	6.49%	21.40%	5.93%	0.00%	0.00%
Revenue Q/Q Growth	0.47%	0.28%	1.08%	2.70%	6.27%	3.01%	2.01%	-0.51%	6.58%	2.59%	20.74%
EBITDA Q/Q Growth	-116.55%	54.91%	-45.30%	16.46%	17.83%	5.39%	-2.25%	11.17%	-0.31%	-9.51%	10.56%
EBIT Q/Q Growth	-60.32%	44.58%	-26.86%	6.49%	16.83%	0.25%	-6.60%	6.43%	3.17%	-4.83%	7.86%
NOPAT Q/Q Growth	14.34%	42.88%	-14.48%	-1.93%	29.13%	-10.58%	3.16%	-4.69%	-0.13%	0.02%	10.63%
Net Income Q/Q Growth	-75.06%	48.07%	-32.00%	2.64%	20.83%	-0.08%	-10.25%	8.98%	5.95%	-1.79%	10.89%
EPS Q/Q Growth	-71.43%	46.15%	-30.00%	0.00%	23.08%	7.14%	-7.69%	7.14%	6.67%	0.00%	11.76%
Operating Cash Flow Q/Q Growth	-254.44%	151.87%	-82.87%	37.15%	70.10%	-338.30%	131.36%	-106.55%	51.13%	-36.12%	-240.83%
Free Cash Flow Firm Q/Q Growth	25.05%	60.17%	-26.54%	8.04%	11.39%	-61.13%	35.41%	-59.57%	80.27%	-6.96%	-3.44%
Invested Capital Q/Q Growth	-1.96%	2.87%	-0.42%	2.79%	0.14%	20.73%	-6.44%	6.41%	-1.22%	8.29%	6.66%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	62.08%	61.24%	52.89%	52.42%	55.19%	47.00%	48.91%	53.41%	54.86%	50.25%	48.45%
EBITDA Margin	-43.46%	-20.16%	-44.85%	-31.20%	-38.35%	-49.60%	-54.01%	-53.88%	-60.34%	-64.11%	-60.06%
Operating Margin	-31.46%	-36.90%	-64.78%	-57.20%	-57.63%	-86.42%	-80.50%	-84.80%	-80.58%	-85.77%	-88.01%
EBIT Margin	-58.52%	-36.68%	-66.36%	-52.88%	-58.07%	-74.20%	-76.63%	-73.32%	-77.96%	-85.81%	-83.98%
Profit (Net Income) Margin	-57.11%	-32.78%	-63.29%	-48.47%	-51.12%	-68.62%	-70.64%	-65.35%	-71.43%	-80.95%	-81.59%
Tax Burden Percent	103.22%	100.12%	102.37%	101.53%	98.59%	100.94%	101.56%	100.90%	99.84%	101.10%	100.39%
Interest Burden Percent	94.55%	89.26%	93.17%	90.28%	89.29%	91.62%	90.77%	88.34%	91.78%	93.31%	96.78%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-26.38%	-30.31%	-57.54%	-47.65%	-48.44%	-70.36%	-73.20%	-74.75%	-66.53%	-124.74%	-124.37%
ROIC Less NNEP Spread (ROIC-NNEP)	-18.54%	-28.86%	-54.12%	-46.14%	-46.70%	-69.17%	-71.35%	-74.02%	-64.77%	-119.85%	-120.14%
Return on Net Nonoperating Assets (RNNOA)	10.65%	16.95%	34.27%	29.43%	31.01%	46.52%	51.43%	53.89%	47.61%	85.78%	89.61%
Return on Equity (ROE)	-15.72%	-13.36%	-23.28%	-18.22%	-17.43%	-23.84%	-21.77%	-20.87%	-18.92%	-38.95%	-34.76%
Cash Return on Invested Capital (CROIC)	-43.02%	-49.71%	-79.97%	-73.25%	-83.13%	-84.78%	-81.63%	-94.00%	-81.60%	-357.67%	-357.88%
Operating Return on Assets (OROA)	-21.41%	-13.19%	-22.70%	-17.28%	-17.62%	-21.82%	-21.54%	-19.67%	-18.94%	-20.15%	-17.22%
Return on Assets (ROA)	-20.89%	-11.78%	-21.65%	-15.84%	-15.51%	-20.18%	-19.85%	-17.53%	-17.36%	-19.01%	-16.73%
Return on Common Equity (ROCE)	-15.72%	-13.36%	-23.28%	-18.22%	-17.43%	-23.84%	-21.77%	-20.86%	-18.92%	-38.95%	-34.76%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-25.43%	-28.75%	-27.05%	0.00%	-27.79%	-27.89%	-27.18%	0.00%	-28.63%	-27.93%
Net Operating Profit after Tax (NOPAT)	-14	-16	-28	-24	-24	-34	-30	-31	-30	-30	-30
NOPAT Margin	-22.02%	-25.83%	-45.35%	-40.04%	-40.34%	-60.49%	-56.35%	-59.36%	-56.41%	-60.04%	-61.61%
Net Nonoperating Expense Percent (NNEP)	-7.84%	-1.45%	-3.42%	-1.51%	-1.75%	-1.19%	-1.85%	-0.73%	-1.77%	-4.89%	-4.23%
Return On Investment Capital (ROIC_SIMPLE)	-3.07%	-	-	-	-4.58%	-	-	-	-5.19%	-	-
Cost of Revenue to Revenue	37.92%	38.76%	47.11%	47.58%	44.81%	53.00%	51.09%	46.59%	45.14%	49.75%	51.55%
SG&A Expenses to Revenue	30.78%	29.57%	34.22%	31.73%	30.41%	36.32%	38.17%	40.85%	37.03%	41.50%	41.06%
R&D to Revenue	37.29%	41.16%	44.60%	42.34%	48.27%	59.59%	49.74%	53.48%	60.09%	55.52%	55.18%
Operating Expenses to Revenue	93.55%	98.14%	117.67%	109.62%	112.82%	133.42%	129.41%	138.21%	135.44%	136.02%	136.46%
Earnings before Interest and Taxes (EBIT)	-36	-22	-41	-32	-34	-41	-41	-39	-41	-43	-41
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-27	-12	-27	-19	-23	-27	-29	-28	-32	-32	-29
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.10	1.40	1.56	0.98	1.25	1.16	1.90	2.01	2.34	2.38	2.33
Price to Tangible Book Value (P/TBV)	7.00	2.32	2.56	1.56	1.94	1.73	2.57	2.67	3.08	3.03	2.95
Price to Revenue (P/Rev)	7.41	2.68	3.13	2.15	2.95	2.87	4.91	5.50	7.04	8.08	9.10
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	7.63	1.89	2.34	1.00	1.71	1.47	3.97	4.20	5.62	5.87	6.25
Enterprise Value to Revenue (EV/Rev)	6.47	1.65	2.04	0.91	1.55	1.37	3.15	3.66	4.90	5.65	6.19
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.57	-0.59	-0.63	-0.64	-0.66	-0.67	-0.72	-0.73	-0.74	-0.72	-0.75
Leverage Ratio	1.39	1.35	1.36	1.32	1.33	1.30	1.29	1.28	1.29	1.26	1.25
Compound Leverage Factor	1.32	1.20	1.27	1.19	1.19	1.19	1.17	1.13	1.18	1.17	1.21
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	3.48	0.34	0.45	-0.04	0.52	0.54	2.06	2.86	3.47	4.51	4.63
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.13	2.34	2.34	2.74	2.71	2.96	3.68	3.89	3.89	4.37	4.12
Quick Ratio	1.96	2.18	2.10	2.49	2.50	2.75	3.51	3.72	3.66	4.13	3.96
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	-27	-67	-53	-58	-65	-40	-63	-39	-199	-186
Operating Cash Flow to CapEx	-49.26%	45.99%	-47.28%	-37.84%	-67.98%	-264.55%	57.70%	-432.52%	-735.24%	-1,022.39%	-521.06%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.37	0.36	0.34	0.33	0.30	0.29	0.28	0.27	0.24	0.23	0.21
Accounts Receivable Turnover	4.93	5.75	5.60	5.89	5.37	5.79	6.29	6.40	4.59	6.05	6.03
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	2.08	2.09	2.02	1.99	1.99	1.87	1.73	1.67	1.58	1.52	1.30
Accounts Payable Turnover	40.20	26.38	36.44	12.59	22.68	29.47	33.48	11.02	19.95	37.76	42.32
Days Sales Outstanding (DSO)	74.05	63.44	65.24	62.00	68.03	63.00	58.00	56.99	79.51	60.36	60.55
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	9.08	13.83	10.02	29.00	16.09	12.39	10.90	33.14	18.30	9.67	8.62
Cash Conversion Cycle (CCC)	64.98	49.60	55.22	33.00	51.94	50.61	47.10	23.86	61.21	50.69	51.93
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	207	211	206	206	201	201	166	178	167	169	156
Invested Capital Turnover	1.20	1.17	1.27	1.19	1.20	1.16	1.30	1.26	1.18	2.08	2.02
Increase / (Decrease) in Invested Capital	6.49	11	39	29	34	32	10	31	9.33	169	156
Enterprise Value (EV)	1,581	400	480	207	343	294	659	746	938	992	974
Market Capitalization	1,810	649	739	491	650	617	1,027	1,122	1,347	1,417	1,432
Book Value per Share	$1.49	$1.58	$1.63	$1.72	$1.80	$1.87	$1.95	$2.03	$2.12	$2.20	$2.28
Tangible Book Value per Share	$0.87	$0.95	$0.99	$1.09	$1.16	$1.25	$1.45	$1.53	$1.61	$1.73	$1.81
Total Capital	441	465	473	500	518	534	540	559	576	594	614
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-229	-249	-258	-284	-307	-323	-368	-376	-409	-425	-458
Capital Expenditures (CapEx)	13	8.86	17	11	10	8.65	17	7.08	2.02	2.97	4.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-69	-76	-71	-65	-74	-66	-56	-53	-56	-55	-76
Debt-free Net Working Capital (DFNWC)	160	173	187	220	234	256	312	323	353	371	382
Net Working Capital (NWC)	160	173	187	220	234	256	312	323	353	371	382
Net Nonoperating Expense (NNE)	22	4.26	11	5.09	6.34	4.50	7.68	3.16	7.96	10	9.68
Net Nonoperating Obligations (NNO)	-234	-253	-268	-294	-317	-333	-373	-382	-409	-425	-458
Total Depreciation and Amortization (D&A)	9.27	10	13	13	12	14	12	10	9.33	11	12
Debt-free, Cash-free Net Working Capital to Revenue	-28.04%	-31.55%	-30.17%	-28.37%	-33.42%	-30.90%	-26.86%	-26.17%	-29.22%	-31.07%	-48.19%
Debt-free Net Working Capital to Revenue	65.54%	71.39%	79.34%	96.12%	105.80%	119.35%	148.99%	158.39%	184.78%	211.36%	242.55%
Net Working Capital to Revenue	65.54%	71.39%	79.34%	96.12%	105.80%	119.35%	148.99%	158.39%	184.78%	211.36%	242.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.12)	($0.07)	($0.13)	($0.10)	($0.10)	($0.13)	($0.14)	($0.13)	($0.14)	($0.15)	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	292.12M	293.34M	290.36M	288.27M	279.59M	284.20M	275.05M	272.35M	267.13M	267.95M	266.21M
Adjusted Diluted Earnings per Share	($0.12)	($0.07)	($0.13)	($0.10)	($0.10)	($0.13)	($0.14)	($0.13)	($0.14)	($0.15)	($0.15)
Adjusted Weighted Average Diluted Shares Outstanding	292.12M	293.34M	290.36M	288.27M	279.59M	284.20M	275.05M	272.35M	267.13M	267.95M	266.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	302.25M	296.71M	293.48M	290.77M	290.62M	287.63M	285.66M	276.03M	274.97M	272.10M	269.88M
Normalized Net Operating Profit after Tax (NOPAT)	-14	-16	-28	-24	-24	-34	-30	-31	-30	-30	-30
Normalized NOPAT Margin	-22.02%	-25.83%	-45.35%	-40.04%	-40.34%	-60.49%	-56.35%	-59.36%	-56.41%	-60.04%	-61.61%
Pre Tax Income Margin	-55.33%	-32.74%	-61.83%	-47.73%	-51.85%	-67.98%	-69.55%	-64.77%	-71.55%	-80.07%	-81.27%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Planet Labs PBC's Financials

When does Planet Labs PBC's fiscal year end?

According to the most recent income statement we have on file, Planet Labs PBC's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Planet Labs PBC's net income changed over the last 5 years?

Planet Labs PBC's net income were at -$123.20 million at the end of 2025, a 12.3% decrease from 2024, and a 0.4% decrease since 2020. See Planet Labs PBC's forecast for analyst expectations on what’s next for the company.

What is Planet Labs PBC's operating income?

Planet Labs PBC's total operating income in 2025 was -$116.12 million, based on the following breakdown:

Total Gross Profit: $139.73 million
Total Operating Expenses: $255.85 million

How has Planet Labs PBC revenue changed over the last 5 years?

Over the last 5 years, Planet Labs PBC's total revenue changed from $95.74 million in 2020 to $244.35 million in 2025, a change of 155.2%.

How much debt does Planet Labs PBC have?

Planet Labs PBC's total liabilities were at $192.51 million at the end of 2025, a 4.6% increase from 2024, and a 309,650.6% increase since 2020.

How much cash does Planet Labs PBC have?

In the past 5 years, Planet Labs PBC's cash and equivalents has ranged from $0.00 in 2020 to $490.76 million in 2022, and is currently $118.05 million as of their latest financial filing in 2025.

How has Planet Labs PBC's book value per share changed over the last 5 years?

Over the last 5 years, Planet Labs PBC's book value per share changed from 0.00 in 2020 to 1.49 in 2025, a change of 247,783.3%.

Related Companies

This page (NYSE:PL) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Planet Labs PBC (PL) Financials

Frequently Asked Questions About Planet Labs PBC's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Planet Labs PBC (PL) Financials

Annual Income Statements for Planet Labs PBC

Quarterly Income Statements for Planet Labs PBC

Annual Cash Flow Statements for Planet Labs PBC

Quarterly Cash Flow Statements for Planet Labs PBC

Annual Balance Sheets for Planet Labs PBC

Quarterly Balance Sheets for Planet Labs PBC

Annual Metrics And Ratios for Planet Labs PBC

Quarterly Metrics And Ratios for Planet Labs PBC

Frequently Asked Questions About Planet Labs PBC's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools